RxDoctor Payments Data

Ralph Ramos, DPM

Foot & Ankle Surgery · Petersburg, VANPI 1659738227

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,055 of the $6,734 with a category attached, or 60.2%. 23 manufacturers reported payments, led by Fortis Surgical, LLC at 25.2% of the total. Reporting peaked in 2023 at $1,847 and has fallen 53.1% since, to $867 in 2025.

$6,734in general payments, 2019–2025

Across 105 payments — averaging $64.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fortis Surgical, LLC$2K
  • Stryker$1K
  • Smith+Nephew$972
  • Amgen$925
  • Celularity Inc.$344
  • Medical Device Business Services, Inc.$315
  • plus $1K from 17 others

What the payments were for

  • Travel & lodging$1,16417%
  • Food & beverage$4,05560%
  • Education$1,51522%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,734 in reported general payments places this provider in the 65th percentile of 260 foot & ankle surgery providers in Virginia.

See all foot & ankle surgery providers in Virginia →

Medicare billing

Part B allowed, 2024
$183,393
Medicare patients
337
Services billed
1,507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate194$4,437
CiclopiroxCiclopirox Olamine173$1,988
Clotrimazole59$717
Ciclopirox14$554
Pregabalin23$447
Gabapentin44$346
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip20$312
Mupirocin20$125
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$102
Silver Sulfadiazine18$100
Meloxicam26$44
Tramadol Hcl23$39

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Petersburg

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →